Your browser doesn't support javascript.
loading
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy.
Shaulov, Adir; Ganzel, Chezi; Benyamini, Noam; Barshay, Yossef; Goldschmidt, Neta; Lavie, David; Libster, Diana; Gural, Alex; Avni, Batia; Gatt, Moshe E.
Afiliación
  • Shaulov A; Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Ganzel C; Department of Hematology, Shaare-Zedek Medical Center, Jerusalem, Israel.
  • Benyamini N; Department of Hematology, Rambam Medical Center, Haifa, Israel.
  • Barshay Y; Barzilai Medical Center, Ashkelon, Israel.
  • Goldschmidt N; Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Lavie D; Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Libster D; Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Gural A; Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Avni B; Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Gatt ME; Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Am J Hematol ; 92(2): 131-135, 2017 02.
Article en En | MEDLINE | ID: mdl-27804150

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Recuperativa / Claritromicina / Amiloidosis / Mieloma Múltiple Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2017 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Recuperativa / Claritromicina / Amiloidosis / Mieloma Múltiple Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2017 Tipo del documento: Article País de afiliación: Israel
...